Good Morning. Welcome to The Wire’s daily news roundup. Each day, our staff gathers the top China business, finance, and economics headlines from a selection of the world’s leading news organizations.
Paid subscribers automatically have this list emailed directly to their inboxes every day by 10 a.m. EST. Subscribe here.
The Wall Street Journal
FDA Approves Cell-Based Multiple Myeloma Therapy Discovered in China — Johnson & Johnson acquired rights to the new drug and conducted studies in the U.S. confirming it worked safely.Billionaire Richard Li’s FWD Files for Hong Kong IPO — Pan-Asian insurer is said to be looking to raise about $1 billion.TikTok Joins Meta in Restricting Access to Russian State Media — A spokesperson for TikTok, a subsidiary of the Chinese company ByteDance Ltd., said Monday that the company has been in communication with the EU and limited access to the Russian-government linked entities.U.S., Allies Are Ramping Up Sanct
Subscribe or login to read the rest.
Subscribers get full access to:
- Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
- A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
- A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our
Subscriptions page for details.
